Cite
Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
MLA
Ou, Qiang, et al. “Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-ΚB Pathway.” Digestive Diseases & Sciences, vol. 63, no. 12, Dec. 2018, pp. 3398–408. EBSCOhost, https://doi.org/10.1007/s10620-018-5268-0.
APA
Ou, Q., Weng, Y., Wang, S., Zhao, Y., Zhang, F., Zhou, J., & Wu, X. (2018). Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway. Digestive Diseases & Sciences, 63(12), 3398–3408. https://doi.org/10.1007/s10620-018-5268-0
Chicago
Ou, Qiang, Yuanyuan Weng, Siwei Wang, Yajuan Zhao, Feng Zhang, Jianhua Zhou, and Xiaolin Wu. 2018. “Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-ΚB Pathway.” Digestive Diseases & Sciences 63 (12): 3398–3408. doi:10.1007/s10620-018-5268-0.